Clinical Trials Directory

Trials / Terminated

TerminatedNCT01583179

Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local Anesthetic Solution

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years – 79 Years
Healthy volunteers
Not accepted

Summary

The patients included will be those who have already agreed to have a brachial plexus nerve block for surgery. A flip of the coin will decide who gets and additive called buprenorphine in their block or not. They will both contain the same amount and type of numbing medicine. The goal will be to see if the additive extends the life of the pain control portion of the ultrasound guided supraclavicular nerve block.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphineadded to nerve block, 0.3mg one time peripheral block use

Timeline

Start date
2012-04-01
Primary completion
2014-03-01
Completion
2015-12-01
First posted
2012-04-23
Last updated
2019-09-11
Results posted
2019-09-11

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01583179. Inclusion in this directory is not an endorsement.

Duration of Analgesic Effect for Ultrasound Guided Supraclavicular Blocks With the Addition of Buprenorphine to Local An (NCT01583179) · Clinical Trials Directory